Replicate design AGAIN [RSABE / ABEL]

posted by Dr Andrew Leary – Ireland, 2011-04-27 14:21 (5114 d 15:02 ago) – Posting: # 6946
Views: 9,046

Dear El Maestro

❝ If I understand your post correctly, your worry seems to be whether patient X is in sequence RR or in sequence RR :-D. Sequence, however, is a between-factor. Try and run the standard model without sequence as a factor on your ref data. And try for comparison to run a normal 2-period study without Sequence as a factor.


My data manager tells me that SAS will not allow sequence to be dropped from the regression (mixed effects?) model.

We've thus fallen at the first hurdle... :-(

Any other ideas?

Regards

Andrew

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
70 visitors (0 registered, 70 guests [including 2 identified bots]).
Forum time: 05:23 CEST (Europe/Vienna)

There are two possible outcomes: if the result confirms the
hypothesis, then you’ve made a measurement. If the result is
contrary to the hypothesis, then you’ve made a discovery.    Enrico Fermi

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5